HEALTH

Carma Labs names new VP sales

BY Michael Johnsen

FRANKLIN, Wis. – Carma Laboratories on Wednesday appointed Frank Simone as VP domestic sales. Simone will be responsible for growing the domestic business for all Carmex brands and products, as well as working with brand partners to expand customer relationships with key retailers.
 
Simone has more than 25 years of experience and most recently served as VP sales for Safeway and Alberston’s at Kellogg’s, and prior to that he spent the majority of his career at Pepsi-Cola North America holding various sales leadership and business development/strategic roles across Pepsi-Cola and Gatorade. Simone also served as market VP at Avery Dennison, where he led two business segments for the retail branding and information solutions divisions and managed private label brands for retailer customers like JC Penney and Macy’s, as well as global brands such as Tommy Hilfiger and Hanes.
 
"I am very pleased at the opportunity to join the leadership team at Carma Labs,” Simone said. “In my new role, I will leverage my years of industry experience to build a comprehensive operating plan across multiple channels, act as a strong people leader and decision-maker, and continue to grow market share and maintain strong customer relationships.”
 
Simone holds a Bachelor of Science degree in Food Marketing from St Joseph’s University and a Masters of Business Administration from Loyola College.
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Smoking-related health costs down in aggressively anti-tobacco state

BY Michael Johnsen

SAN FRANCISCO — One of the first states to implement a comprehensive tobacco program, California has realized an actual cost decrease of more than 13% for smoking-attributable costs for 2009, according to an article in Nicotine & Tobacco Research published Wednesday.
 
Researchers estimated expenditures for smoking-attributable costs (healthcare, lost productivity from illness and lost productivity from premature mortality) in 2009 came to $18.1 billion, amounting to $487 per California resident and $4,603 per smoker.
 
In two previous studies, conducted in 1989 and 1999, the annual financial impact of smoking on California's economy was tallied at $7.6 billion and $15.8 billion, respectively. Nominally, the figures show a 15% increase in the last decade, but inflation-adjusted totals show a very different picture: the total cost of smoking in 1999 expressed in 2009 constant dollars was $20.8 billion. Real costs have actually decreased by over 13%.
 
"The California tobacco control program has been very effective," stated Wendy Max, the study's lead author. "But there remains work to be done, especially in light of the changing landscape of tobacco products."
 
Many recent changes in smoking behavior are thought to have contributed to the 13% decline. Adult smoking prevalence in California has fallen from 21.6% of adults in 1989, to 18.7% in 1999 and to 13.6% in 2009. In 2010, that number fell again with just 11.9% of the state's adults smoking. 
 
Additionally, among those who continue to smoke, there has been a downward trend in smoking intensity – more smokers fell into the category of "nondaily" smokers, and both nondaily and daily smokers reported smoking fewer cigarettes per day, on average. Population shifts in the state, including a greater proportion of Hispanic and Asian Californians, are also worth noting, as these two population groups both have relatively low smoking prevalence.
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Redwood Scientific to introduce new smoking cessation product in 2016

BY Michael Johnsen

LOS ANGELES – Redwood Scientific Technologies on Tuesday announced the launch of TBX-FREE: a new thin film over-the-counter smoking cessation product that features an ingredient that mimics the sensation of smoking without any of the harmful side effects.
 
"We are now proud to be able to synthesize such an incredibly proven ingredient and put it into the form of dissolvable strip delivery technology so that people who suffer with addiction to tobacco-based cigarettes can have over-the-counter access to a smoking cessation treatment that does not use nicotine while enjoying the freedom to live without fear of death," stated Jason Cardiff, president and CEO of Redwood.
 
Ben England, CEO at FDAImports.com, will be overseeing the FDA registration process for TBX-FREE. "We are very excited about the idea of a new treatment to help with nicotine addiction and look forward to working with Redwood and their revolutionary delivery method for the treatment of nicotine addiction," said England.
 
TBX-FREE will come packaged in the form of discrete thin film containers that look identical to breath freshening strips so that smokers can have it on hand to help quickly address cravings and withdrawal symptoms associated with quitting smoking.
 
TBX-FREE will be the second product from the Redwood product pipeline and is scheduled to launch in the third quarter of 2016.
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?